Full-Time

Account Operations Specialist

NE Region

Posted on 8/7/2024

Adaptive Biotechnologies

Adaptive Biotechnologies

501-1,000 employees

Decodes immune cell genetic information for diagnostics

Biotechnology
Healthcare

Compensation Overview

$67.7k - $94.3kAnnually

+ Equity Grant + Bonus Eligible

Junior, Mid

No H1B Sponsorship

Remote in USA

Category
Customer Success
Customer Support
Customer Success & Support
Required Skills
Customer Service
Requirements
  • Bachelor’s degree + 2 years of related experience
  • 1-2 years prior Client Services or Customer Training/Support experience is strongly preferred.
  • Proactive approach to work; strong personal drive and desire for feedback.
  • Strong customer and patient focus with a clear understanding of HIPAA requirements.
  • Must have strong analytical and planning skills with keen attention to detail and meticulous data entry skills.
  • Effective project collaborator able to work autonomously to advance the team toward agreed-upon goals.
  • Strong interpersonal and organizational skills with excellent listening, oral and written communication skills.
Responsibilities
  • Support two sales regions to ensure timely access to clonoSEQ ordering for providers and care teams
  • Manage provider onboarding process for expedited ordering and customers who have clonoSEQ integrated in their EMR
  • Build and maintain strategic relationships with customers and drive satisfaction through superior service and execution.
  • Collaborate with Account Operations Leads to manage internal process for addressing institution-specific onboarding requirements.
  • Ensure accurate and timely reporting of information related to new prospects.
  • Serve as customer liaison for priority internal initiatives requiring customer engagement.
  • Educate customers on new support offerings to maximize brand performance.
  • Manage clonoSEQ collection kit inventory in your two regions
  • Collaborate with the Clinical Services team to ensure efficient and effective communication with clinicians and their care team.
  • Serve as a point of customer escalation engagement
  • Contribute to a culture of success and ongoing business and goal achievement.
  • Support patient pull through efforts with timely customer follow-up and reporting.
Adaptive Biotechnologies

Adaptive Biotechnologies

View

Adaptive Biotechnologies focuses on using the immune system to improve disease diagnosis and treatment. The company decodes genetic information from immune cell receptors, which are essential for the immune system's ability to identify and respond to diseases. One of their key projects is the ImmuneRACE study, which analyzes blood samples and swabs from participants to understand how the immune system reacts to COVID-19. This research aims to enhance diagnostics, treatments, and vaccines for the virus. Adaptive Biotechnologies uses advanced data algorithms to analyze immune cell genetics and generates revenue through partnerships with pharmaceutical companies, licensing technology, and offering diagnostic services. Their goal is to advance healthcare by leveraging immune system data to develop better therapies and diagnostic tools.

Company Stage

IPO

Total Funding

$395.8M

Headquarters

Seattle, Washington

Founded

2009

Growth & Insights
Headcount

6 month growth

-5%

1 year growth

-11%

2 year growth

-15%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strong partnerships with pharmaceutical companies enhance revenue and innovation.
  • Recent investments indicate confidence in Adaptive's growth potential.
  • Integration with Epic could streamline healthcare diagnostics.

What critics are saying

  • Increased competition from startups focusing on large language models.
  • Potential conflicts from partnership with EndoSound on endoscopy device.
  • Regulatory challenges in collaboration with BeiGene for clonoSEQ assay.

What makes Adaptive Biotechnologies unique

  • Pioneers in immune-driven medicine, leveraging adaptive immune system for diagnostics.
  • FDA-authorized clonoSEQ test for minimal residual disease in blood cancers.
  • Unique focus on decoding immune cell receptors for better diagnostics and treatments.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE